Ming Yang

Ming Yang discloses dealings in China Biologic Products, Inc. to SEC (Form 4). We count 15 filings; the first trade dates from 31 August 2012 and the latest from 15 August 2016.

Sales make up the whole of the open-market record (7 sales, €5.7M). Other entries cover 5 share grants and 3 option exercises. So far in 2016, the count stands at no purchases and 3 sales.

The latest filing, published on 17 August 2016, reports an open-market sale of €2.3M in China Biologic Products, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.